SAHPRA approves Pfizer booster dose in S Africa to curb Omicron variant

The South African Health Products Authority (SAHPRA) has approved a third booster dose for South Africans following the outbreak of the Omicron Covid-19 variant. This follows concerns at early evidence suggesting that the Omicron has a higher re-infection risk.

from Engineering News | Home https://ift.tt/3EEjHpp